Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
clinical trials
fda
5
×
life sciences
national blog main
boston blog main
boston
boston top stories
deals
investing
new enterprise associates
san diego blog main
san diego top stories
san francisco blog main
achaogen
adams street partners
akouos
antibiotics
astellas pharmaceuticals
bempedoic acid
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
california institute for biomedical research
cancer
cancer drugs
cholesterol
corticosteroids
decibel therapeutics
deciphera pharmaceuticals
detroit
detroit blog main
detroit top stories
drug resistance
drugs
dyne therapeutics
eli lilly
What
drug
medicines
5
×
therapeutics
5
×
ipo
approved
company
developing
fda
affects
americans
bacteria
biopharma
biotech
black
brings
business
cancer
cholesterol
clinic
combo
companies
date
diamond
disease
disorders
dyne
dyne’s
eluded
esperion
esperion’s
exited
fighting
frequency
genetic
hearing
hopes
infections
infectious
launches
lead
Language
unset
Current search:
fda
×
biotech
×
therapeutics
×
medicines
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
